Ibuzatrelvir is an orally bioavailable inhibitor of the SARS-CoV-2 main protease (Mpro, also called 3C-like protease). It reversibly binds the catalytic cysteine Cys145, blocking cleavage of viral polyproteins needed for viral replication. It is studied in COVID-19 and SARS-CoV-2 infection.
Summary written with AI from the sources listed at the end of this page.
At a glance
Also known as
PF-07817883
Drug type
Small molecule
Targets
SARS-CoV-2 main protease (Mpro; 3C-like protease; nsp5)
Mechanism
Inhibitor of SARS-CoV-2 main protease (Mpro; 3C-like protease; nsp5)
Pathways
viral polyprotein processing, viral transcription and replication
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.